Journals
Publish with us
Publishing partnerships
About us
Blog
Depression Research and Treatment
Journal overview
For authors
For reviewers
For editors
Table of Contents
Special Issues
Depression Research and Treatment
/
2014
/
Article
/
Tab 2
/
Clinical Study
Lovastatin as an Adjuvant to Lithium for Treating Manic Phase of Bipolar Disorder: A 4-Week, Randomized, Double-Blind, Placebo-Controlled Clinical Trial
Table 2
The rate and dose of concomitant medications by the groups.
Medication
Lovastatin group (number)
Placebo group (number)
Haloperidol (10 mg/day)
1
1
Perphenazine (24 mg/day)
4
2
Olanzapine (5–15 mg/day)
7
4
Risperidone (1–6 mg/day)
3
2
Thioridazine (100 mg/day)
1
1
Imipramine (25 mg/day)
1
0
Valproate sodium (200–800 mg/day)
6
3
Lamotrigine (100 mg/day)
0
1
Clonazepam (1.5 mg/day)
1
1
Propranolol (20 mg/day)
2
1
Bupropion
0
1
Clozapine (12.5–25 mg/day)
0
2
Carbamazepine (400 mg/day)
0
2